Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17325700 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
Condition: Central Nervous System Tumors
Interventions: Radiation: Radiotherapy;   Drug: nedaplatin;   Drug: vincristine;   Drug: Temozolomide

Indicates status has not been verified in more than two years